Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

84 ArticlesPharmaceuticals

1 / 9

Outlier in Focus – Divi’s Laboratories.

We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Divi's ...
Outlier-in-Focus.png

Dr Reddy’s USFDA Inspection of Oncology Formulation Manufacturing Facility at Duvvada – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s oncology formulation manufacturing facility at Duvvada at Visakhapatnam, Andhra Pradesh. ...
Dr-Reddy-Duvvada-1.png

Cadila Healthcare US FDA Inspection of Baddi – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Cadila Healthcare’s formulations manufacturing plant at Baddi. On another note, the company is due ...
Cadila-483.png

Dr Reddy’s Laboratories US FDA Inspection of Miryalaguda – Form 483 Revealed

Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s API manufacturing plant at Miryalaguda. On another note, the company’s formulation ...
Dr-Reddy-Miryalguda-2.png

We Reveal The Observations Made By US FDA’s Inspection Of Natco’s Kothur Facility

True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...
Natco-Kothur-483.png

Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Granules OmniChem's Vizag Facility

True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...
Granules-OmniChem.jpg

“They’re getting away with murder” – How Big A Bite Will Trump Take?

How do you make a first impression? Something like what the American President-elect Donald Trump did in his first press conference since being elected the ...
Trump-Comments-Pharma.png

We Reveal The Form 483 Issued By US FDAs Inspection Of Divis Laboratories Unit-II At Visakhapatnam

Here is our coverage of the Form 483 issued by the US FDA from the inspection of Divis Laboratories Unit-II located at Visakhapatnam. You can catch all our ...
Divis-Laboratories-FDA-Inspection.png

Exclusive: We Reveal The Observations Made By US FDA’s Inspection Of Sun Pharma’s Halol Facility

True to our promise of keeping a tab on the US FDAs inspection of Sun Pharma’s Halol facility, we are happy to get our hands on the Form 483 issued for ...
US-FDA-Sun-Pharma-Halol-Form-483-2.png

Alkem Laboratories & Divis Laboratories Receive Form 483 From US FDA

With the dust yet to settle on the US FDAs inspection of Sun Pharmaceuticals Mohali, Punjab and Halol, Gujarat plants, 2 more companies have reported receiving ...
Alkem-Manufacturing-Plants.png